I’m sitting across from a room full of suits—executives from a global healthcare giant, all puffed up about their shiny new AI toy. They’ve called me in to poke at their strategy, but their shoulders are hunched, their smiles tight. Something’s off. The Chief Information Officer—a guy who knows his stuff, no question—dives into the nitty-gritty of their latest triumph: a large language model that’s tamed their data nightmare. Picture this: stacks of scribbled patient forms, a digital mess of files, all whipped into one neat record. They’ve sunk over a year into building and testing it, and it works. They’re beaming. I’m not.
“Solid start,” I tell them, leaning back in my chair. “But you’re still at square one.” The room goes quiet—pins dropping would’ve sounded like thunder. They’ve poured cash and sweat into this AI, rolled it out with a pilot that didn’t crash, and figured the finish line was in sight. Wrong. Like so many big shots who’ve spent the last year tinkering with AI, they’ve mistaken the first step for the whole race. Truth is, AI’s just one piece of a bigger storm brewing—and if they don’t wake up to the rest, they’ll be swept away.
Living Intelligence: The Real Game-Changer
Let’s get one thing straight: their AI focus wasn’t a misstep. Late? Sure. But right? Absolutely. Problem is, large language models (LLMs) like theirs are the opening act, not the headliner. Tech’s moving fast—faster than these execs can shuffle their PowerPoint slides. To keep up, they’ll need to flex a new muscle: constant change. Why? Because AI’s got two quiet sidekicks—advanced sensors and biotech—that are about to steal the show. Together, these three are birthing what I call “living intelligence”: systems that don’t just think, but feel, adapt, and grow.
This isn’t sci-fi—it’s the future, and it’s already knocking. Living intelligence will spark a wildfire of innovation, torching old industries and lighting up new ones. Leaders who fixate on AI alone? They’re like folks admiring a single wave while a tsunami builds offshore. I told the team as much: “You’ve got the brains, but you’re missing the senses and the guts.” They blinked. I grinned. Time to school them.
Sensors: The Data-Hungry Eyes of Tomorrow
AI’s the engine, sure—but engines need fuel. That’s where sensors come in, gobbling up data like kids at a candy store. These little spies are everywhere already, and most folks don’t even notice. Your iPhone’s got a dozen—proximity sensors, face ID, you name it—tracking your every move. Companies like Xylem are using them to tackle water woes, with smart meters that sniff out leaks by watching flow patterns in real time. Then there’s the wild stuff: wearable biosensors and nanobots—tiny machines swimming in your blood, texting your doc about your health (check out the latest on nanobots here).
Soon, sensors won’t just grab more data—they’ll grab different data. That flood’s going to drown LLMs and birth something bigger: large action models (LAMs). Unlike LLMs, which chatter away, LAMs do stuff—breaking tasks into bite-sized chunks and acting on them. Think Anthropic’s Claude or Adept’s ACT-1, already playing with code and apps like digital handymen. LAMs will feast on sensor data—from your phone, your car, your smart fridge—making split-second calls without you lifting a finger.
But wait—it gets personal. LAMs will morph into PLAMs—personal large action models—tailored to you. They’ll chat with your devices, learn your habits, and handle your life: booking flights, tweaking playlists, even haggling with other PLAMs—all while keeping your secrets safe. Big players like Apple and Google are already stuffing gadgets with sensors to build these profiles. Meanwhile, corporations will get CLAMs, and governments? GLAMs. Yeah, it’s a mouthful—but it’s coming.
Biotech: The Underdog That’ll Outlast ‘Em All
Now, let’s talk biotech—the scrappy third wheel that might just outshine the rest. Bioengineering’s cooking up designer bugs and tissues, paired with AI to whip up “generative biology” (genBio). This isn’t just lab geekery—it’s rewriting life. Ginkgo Bioworks is engineering enzymes to eat plastic pollution, while Google DeepMind’s AlphaProteo dreams up proteins for drugs or eco-friendly materials. Their GNoME tool’s predicted millions of new materials—think buildings that breathe without a plug (read more here).
Further out? Living machines. Organoid intelligence (OI) hit the scene in 2024, growing brain-like tissues into biological PCs. Take Cortical Labs’ DishBrain—a million human and mouse brain cells playing Pong on a chip. It learns. It gets better. They’re even building a bio-OS so anyone with basic coding chops can join the fun. Biotech’s the long game, folks—and it’s a doozy.
The Oppressed Get a Voice—If Leaders Listen
Here’s where I get loud: this tech trifecta isn’t just for the C-suite fat cats. It’s a lifeline for the little guy—the patients buried under healthcare red tape, the workers drowned in busywork, the communities choked by dirty water or air. Living intelligence could flip the script, but only if leaders stop navel-gazing. The healthcare execs I met? They’re sitting pretty with their AI win, but they’re blind to the bigger fight. Patients deserve diagnostics that don’t bankrupt them, systems that don’t lose their files in the shuffle. Sensors and biotech could deliver—if the suits care enough to try.
I’ve seen this before: power hoards tech, and the rest get scraps. Not this time—not if we push back. These tools could democratize health, clean up messes, and cut through bureaucracy. But left unchecked? They’ll pad profits for the already-rich while the rest of us dodge nanobots spying for ad dollars. Truth’s my north star, and it’s screaming: this convergence is a chance to lift the downtrodden—or bury them deeper.
Five Moves to Stay Ahead (And Not Screw the Rest)
So, how do you ride this wave without wiping out? I gave the healthcare crew five no-nonsense tips—same ones I’d give any leader who’s not asleep at the wheel:
Spread the Word. Get everyone—top to bottom—clued in on living intelligence. AI, sensors, biotech—it’s a team sport.
Dream Big, Plan Smart. Sketch out how this tech could shake things up short-term and long haul. Map it to your business, not just your bonus.
Start Small, Win Big. Pick a couple high-impact projects—say, sensor-driven patient monitoring—and run with them. Scale what works.
Train the Troops. This isn’t plug-and-play. Teach your people to roll with it—new skills, new roles, new guts.
Watch the Rules. Regs are a mess—always will be. Stay nimble, test bold ideas, and shape the game before it shapes you.
Then I hit them with the kicker: “What if?” What if health became a subscription—wearables, AI diagnostics, custom meds on your doorstep? What if startups leapfrogged hospitals with sensor-driven care? What if your bathroom mirror ratted out your cholesterol? What if providers got paid for results, not visits? The execs squirmed. Good—they should.
The Finish Line’s a Mirage—Keep Running
“Look,” I told them, smirking, “AI’s not your trophy—it’s your running shoes. Lace up.” They laughed, but I wasn’t kidding. Living intelligence is barreling toward us, and it’s not waiting for anyone to catch their breath. The healthcare bigwigs aren’t alone—every industry’s got execs slapping backs over AI wins, blind to the real rumble. Sensors and biotech are the quiet rebels, ready to upend everything.
Me? I’m no prophet—just a guy who’s tired of seeing the powerful hog the future while the rest scramble. This tech could be a great equalizer, or another boot on the neck. I’m betting on the former, but only if we fight for it. So, to the suits and the dreamers alike: don’t stop at AI. Peek around the corner. The oppressed—the sick, the ignored, the overworked—they’re counting on it. And frankly, so’s the truth.
